Skip to main content
Premium Trial:

Request an Annual Quote

EOS Biotechnology, Incyte Genomics, Surmodics


EOS Biotechnology of South San Francisco received US Patent No. 6,516,276, “Method and apparatus for analysis of data from biomolecular arrays.” The patent covers an application for analyzing data from biomolecular binding experiments that collects data from probes and generates probability values on bindng success. Normalized values are generated and data is ouput incuding normalized values and probablility values for the array probe sets.

Incyte Genomics of Palo Alto, Calif., received US Patent No. 6,514,751, “Linear microarrays.” The patent provides a method for detecting the presence of polynucleotide sequence in a sample. The system uses volumes in the range of 10 nanoliters to 10 microliters for sample delivery, hybridization, or washes. It is constructed of capillary-like casings, with input and output openings, and a substrate immobilized in each of the casings.

Surmodics of Eden Prairie, Minn., received US Patent No. 6,514,768, “Replicable probe array.” The patent covers a system for producing nucleic acid-based arrays by replicating an original master array, or providing a reusable assay capable of being regenerated.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.